Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials.
about
The spread, treatment, and prevention of HIV-1: evolution of a global pandemicTuberculosis control: challenges of an ancient and ongoing epidemicIsoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized TrialsPreventive therapy in children exposed to Mycobacterium tuberculosis: problems and solutionsDiagnosis & treatment of tuberculosis in HIV co-infected patients.Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list'Diagnosis and treatment of latent infection with Mycobacterium tuberculosisBarriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study.Updates on the risk factors for latent tuberculosis reactivation and their managementsImpact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001Differential producibility analysis (DPA) of transcriptomic data with metabolic networks: deconstructing the metabolic response of M. tuberculosisPopulation health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluationGranuloma encapsulation is a key factor for containing tuberculosis infection in minipigsM. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis.Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in peri-urban Kampala, UgandaHigh-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area.Latent tuberculosis among pregnant mothers in a resource poor setting in Northern Tanzania: a cross-sectional study.Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV.Effect of tuberculosis preventive therapy on HIV disease progression and survival in HIV-infected adultsA re-examination of the potential impact of preventive therapy on the public health problem of tuberculosis in contemporary sub-Saharan Africa.Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in South-Western Uganda.Risk factors for non-adherence and loss to follow-up in a three-year clinical trial in BotswanaFine mapping of genetic polymorphisms of pulmonary tuberculosis within chromosome 18q11.2 in the Chinese population: a case-control study.Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected personsPrevalence of pulmonary tuberculosis and immunological profile of HIV co-infected patients in Northwest Ethiopia.Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West Africa.Impact of blood volume, tube shaking, and incubation time on reproducibility of QuantiFERON-TB gold in-tube assay.HIV-prevalence in tuberculosis patients in Germany, 2002-2009: an estimation based on HIV and tuberculosis surveillance data.Timing of antiretroviral therapy for HIV in the setting of TB treatment.Tuberculosis as part of the natural history of HIV infection in developing countriesBeneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populationsImpact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model.Incidence and risk factors of tuberculosis in patients with human immunodeficiency virus infectionIsoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.Implementation of tuberculosis infection control in health facilities in Mukono and Wakiso districts, Uganda.The use of anti-tuberculosis therapy for latent TB infectionAntituberculosis drug-induced hepatotoxicity in childrenEfficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis.Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana.
P2860
Q22241890-299014B9-5189-4839-85C2-A2A194090DEDQ26206908-A804A6F7-CCF8-42AE-A8EA-83D4529C7F7DQ26778385-C03B4595-50C4-4D70-A616-8146A594F2D9Q26851747-7C25D3F9-CF70-4A8F-A8CA-475C41E24E30Q26991633-CAE9B86C-7978-47BB-8667-9058A1D860EBQ27015848-69C6C119-53E7-44F8-853B-F1AE42F632C7Q27021614-01391036-994D-420D-8D4E-A45EDA988530Q27309915-54C3243B-A2E5-47E1-AECC-3CF0D8DC260DQ28073158-A0C39A10-384C-4783-906A-B2DEB7D31D2FQ28469286-3128BDD0-96F8-4D84-BDAC-6D553457ADEAQ28478889-0B1EF80E-5EE8-4FA4-8F58-64F34695487CQ28485280-294E70C4-B3F4-4C9E-9B84-F14C1E53DB72Q28748169-9B47EB3D-1C9A-463B-9CBF-30F1CE61A21EQ33286329-ED130847-B642-4FFD-A511-2FDC5F8F418BQ33344474-36EF0C0E-2CA2-4251-8D1B-45D33A3D95A5Q33355670-D9FEBB82-F3C0-41C1-ABA0-DBB613709CC4Q33454961-06BE7B7F-BF16-475E-B4AD-C4930F584993Q33537470-7110B264-FC37-49B1-BF2D-ABDBF15C5546Q33793347-0BE4A0E4-4F2E-4C13-A5B3-481600291BE2Q33813132-920CF84F-F7C8-4F19-BF29-023A709D53D8Q33813159-1F61DF97-9593-47D8-BE5C-807B8F4FA0F3Q33858850-1437E44C-5112-4FCC-83BB-BC5836B3BE4CQ33889133-5EC40E78-0CCE-46AB-AB9F-42A09192ECB4Q34054030-F0082695-B40D-434E-88DC-D32DD19514E5Q34163313-CD848495-D3F9-4782-BB63-F23F1395988CQ34318819-B7039CC7-CF6F-443D-AA01-EF87D5858A74Q34351266-775ABA66-F33B-418B-8A27-8C5C427195B1Q34365728-03B3EA35-0A9B-48EA-999E-CF113799D561Q34474070-C8A7C4C0-686B-4543-90D6-FA615802983FQ34475542-62384802-225A-4991-9D1C-5ECD1CD83F4EQ34547644-DBD319E4-2BD8-4B8D-B60D-6D4FA3FAB85CQ34598512-F76DCA74-DBE3-4AF1-B5B3-48D67FB3D097Q34639121-E7821A85-94CF-4F00-8F66-C443EBED705DQ34649281-30546891-CBF0-4A4B-9492-ACBEAE2D09F2Q34717889-22778B2B-2694-4351-AE05-B4891E68EE33Q34895110-EFC26057-6E7F-4BA5-9F72-D5FCB0A73839Q35026573-ADDB8993-65F5-404A-86EA-1CF217A9EDFBQ35096954-504D9B1B-A587-4433-B106-858783439675Q35098753-5792356B-251D-4494-B074-6F602EF8873AQ35173497-E39916D2-2FD1-46A9-8F38-2BE93DBFD821
P2860
Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Isoniazid prophylaxis for tube ...... randomized controlled trials.
@en
type
label
Isoniazid prophylaxis for tube ...... randomized controlled trials.
@en
prefLabel
Isoniazid prophylaxis for tube ...... randomized controlled trials.
@en
P2093
P921
P1433
P1476
Isoniazid prophylaxis for tube ...... randomized controlled trials.
@en
P2093
Battegay M
Griffith LE
P304
P356
10.1097/00002030-199903110-00009
P407
P577
1999-03-01T00:00:00Z